MPEX PHARMACEUTICALS INC.;TRIPEX PHARMACEUTICALS LLC;RAPTOR PHARMACEUTICALS INC.
发明人:
申请号：
IL21219011
公开号：
IL212190A
申请日:
2011.04.06
申请国别(地区):
IL
年份:
2017
代理人:
摘要：
The present invention relates to the field of antimicrobial agents. In particular, the present invention relates to the use of aerosolized fluoroquinolones formulated with divalent or trivalent cations and having improved pulmonary availability for the treatment and management of bacterial infections of the lung and upper respiratory tract.
